Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kamuvudine-9 in Diabetic Macular Edema
NCT07458061Phase 2Recruiting
- Sponsor
- Dr. Bryan Strelow
- Start
- Feb 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of kamlanoflast in diabetic macular edema (DME), sponsored by Dr. Bryan Strelow. Started Feb 2026; status: recruiting.
02
Drugs
kamlanoflast
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT07458061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07458061.